Viking Therapeutics has experienced an 11% monthly decline in its stock price, a notable movement amid its recent announcements and a wider market downturn. The company completed the enrollment ...

Viking Therapeutics, Inc. (VKTX) closed the latest trading day at $23.91, indicating a -0.99% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 0 ...

Viking soared more than 100% in one trading session last year on positive clinical trial news. The stock has since given up those gains, but its weight loss drug program continues to advance and ...

Viking Therapeutics (NASDAQ: VKTX) is operating in one of the highest-growth pharma areas around. I'm talking about the weight loss drug market -- one that Morgan Stanley analysts say may multiply by ...

In somewhat of a surprise move, Viking Therapeutics just announced a production deal with CordenPharma, a privately held Swiss company. The move supports the commercial launch of a drug just now ...

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) has been given a consensus rating of “Buy” by the thirteen research firms that are covering the firm, MarketBeat reports. One ...